Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Iza-Bren Is Approved in China for Recurrent/Metastatic Nasopharyngeal Carcinoma
Novartis to acquire Myricx Bio for up to $1.5B, adding cancer-fighting ADC payload platform
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals
Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio

Leveraging Novel Process & Technology Options to Optimize Vial Fogging Challenges in ADC DP Manufacturing

Leveraging Novel Process & Technology Options to Optimize Vial Fogging Challenges in ADC DP Manufacturing

12:00 pm - Monday 12th October 2026

Highlighting the importance of optimizing container selection and process levers to optimize ADC DP lyophilization
Optimizing ADC DP manufacturing process to reduce challenges with vial fogging through hydrophobic vial technology
Showcasing learnings within ADC manufacturing control strategy

Speakers:

Mohsina Rahman

Mohsina Rahman

Senior Scientist, Engineering, Sterile Drug Product Commercialization

Merck & Co